REBECCA JO RENN: Open Payments
NPI 1457319071 · OLYMPIA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,546 in 73 payments from 10 companies in 2025. Trend: 2023 $208 · 2024 $400 · 2025 $1,546
Food & beverage: $1,546
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 11 | $324 |
| Lundbeck LLC | 12 | $233 |
| Otsuka America Pharmaceutical, Inc. | 9 | $206 |
| ABBVIE INC. | 16 | $186 |
| Teva Pharmaceuticals USA, Inc. | 12 | $185 |
| Alkermes, Inc. | 5 | $132 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $107 |
| Axsome Therapeutics, Inc. | 1 | $92 |
| Janssen Pharmaceuticals, Inc | 2 | $57 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
Products named: COBENFY, REXULTI, VRAYLAR, ABILIFY MAINTENA, AUSTEDO XR, ARISTADA, CAPLYTA, Auvelity.
Industry payments across WA — which companies pay providers there.
